These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 11053628

  • 1. Lack of CIITA expression is central to the absence of antigen presentation functions of trophoblast cells and is caused by methylation of the IFN-gamma inducible promoter (PIV) of CIITA.
    van den Elsen PJ, van der Stoep N, Viëtor HE, Wilson L, van Zutphen M, Gobin SJ.
    Hum Immunol; 2000 Sep; 61(9):850-62. PubMed ID: 11053628
    [Abstract] [Full Text] [Related]

  • 2. Transcriptional control of MHC genes in fetal trophoblast cells.
    van den Elsen PJ, Gobin SJ, van der Stoep N, Datema G, Viëtor HE.
    J Reprod Immunol; 2001 Sep; 52(1-2):129-45. PubMed ID: 11600183
    [Abstract] [Full Text] [Related]

  • 3. Class II transactivator (CIITA) promoter methylation does not correlate with silencing of CIITA transcription in trophoblasts.
    Holtz R, Choi JC, Petroff MG, Piskurich JF, Murphy SP.
    Biol Reprod; 2003 Sep; 69(3):915-24. PubMed ID: 12748124
    [Abstract] [Full Text] [Related]

  • 4. Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expression.
    Murphy SP, Tomasi TB.
    Mol Reprod Dev; 1998 Sep; 51(1):1-12. PubMed ID: 9712312
    [Abstract] [Full Text] [Related]

  • 5. Lack of IFN-gamma-mediated induction of the class II transactivator (CIITA) through promoter methylation is predominantly found in developmental tumor cell lines.
    van der Stoep N, Biesta P, Quinten E, van den Elsen PJ.
    Int J Cancer; 2002 Feb 01; 97(4):501-7. PubMed ID: 11802213
    [Abstract] [Full Text] [Related]

  • 6. Regulation of the expression of MHC class I and II by class II transactivator (CIITA) in hematopoietic cells.
    Liu A, Takahashi M, Toba K, Zheng Z, Hashimoto S, Nikkuni K, Furukawa T, Koike T, Aizawa Y.
    Hematol Oncol; 1999 Dec 01; 17(4):149-60. PubMed ID: 10725870
    [Abstract] [Full Text] [Related]

  • 7. Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA.
    Geirsson A, Paliwal I, Lynch RJ, Bothwell AL, Hammond GL.
    Transplantation; 2003 Jul 27; 76(2):387-94. PubMed ID: 12883198
    [Abstract] [Full Text] [Related]

  • 8. MHC class II gene silencing in trophoblast cells is caused by inhibition of CIITA expression.
    Morris AC, Riley JL, Fleming WH, Boss JM.
    Am J Reprod Immunol; 1998 Dec 27; 40(6):385-94. PubMed ID: 9894561
    [Abstract] [Full Text] [Related]

  • 9. Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation.
    Soos JM, Krieger JI, Stüve O, King CL, Patarroyo JC, Aldape K, Wosik K, Slavin AJ, Nelson PA, Antel JP, Zamvil SS.
    Glia; 2001 Dec 27; 36(3):391-405. PubMed ID: 11746775
    [Abstract] [Full Text] [Related]

  • 10. Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma.
    Piskurich JF, Gilbert CA, Ashley BD, Zhao M, Chen H, Wu J, Bolick SC, Wright KL.
    Mol Immunol; 2006 Feb 27; 43(6):519-28. PubMed ID: 15950283
    [Abstract] [Full Text] [Related]

  • 11. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma.
    Lu HT, Riley JL, Babcock GT, Huston M, Stark GR, Boss JM, Ransohoff RM.
    J Exp Med; 1995 Nov 01; 182(5):1517-25. PubMed ID: 7595221
    [Abstract] [Full Text] [Related]

  • 12. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity.
    Sartoris S, Valle MT, Barbaro AL, Tosi G, Cestari T, D'Agostino A, Megiovanni AM, Manca F, Accolla RS.
    J Immunol; 1998 Jul 15; 161(2):814-20. PubMed ID: 9670958
    [Abstract] [Full Text] [Related]

  • 13. Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cells.
    Croce M, De Ambrosis A, Corrias MV, Pistoia V, Occhino M, Meazza R, Giron-Michel J, Azzarone B, Accolla RS, Ferrini S.
    Oncogene; 2003 Oct 30; 22(49):7848-57. PubMed ID: 14586411
    [Abstract] [Full Text] [Related]

  • 14. Methylation of class II trans-activator promoter IV: a novel mechanism of MHC class II gene control.
    Morris AC, Spangler WE, Boss JM.
    J Immunol; 2000 Apr 15; 164(8):4143-9. PubMed ID: 10754309
    [Abstract] [Full Text] [Related]

  • 15. MHC class II transactivator (CIITA) expression is upregulated in multiple myeloma cells by IFN-gamma.
    Zhao M, Flynt FL, Hong M, Chen H, Gilbert CA, Briley NT, Bolick SC, Wright KL, Piskurich JF.
    Mol Immunol; 2007 Apr 15; 44(11):2923-32. PubMed ID: 17300840
    [Abstract] [Full Text] [Related]

  • 16. Histone deacetylation, but not hypermethylation, modifies class II transactivator and MHC class II gene expression in squamous cell carcinomas.
    Kanaseki T, Ikeda H, Takamura Y, Toyota M, Hirohashi Y, Tokino T, Himi T, Sato N.
    J Immunol; 2003 May 15; 170(10):4980-5. PubMed ID: 12734341
    [Abstract] [Full Text] [Related]

  • 17. Kinetics of a gamma interferon response: expression and assembly of CIITA promoter IV and inhibition by methylation.
    Morris AC, Beresford GW, Mooney MR, Boss JM.
    Mol Cell Biol; 2002 Jul 15; 22(13):4781-91. PubMed ID: 12052885
    [Abstract] [Full Text] [Related]

  • 18. Increased binding of IFN regulating factor 1 mediates the synergistic induction of CIITA by IFN-gamma and tumor necrosis factor-alpha in human thyroid carcinoma cells.
    Rahat MA, Chernichovski I, Lahat N.
    Int Immunol; 2001 Nov 15; 13(11):1423-32. PubMed ID: 11675374
    [Abstract] [Full Text] [Related]

  • 19. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.
    Satoh A, Toyota M, Ikeda H, Morimoto Y, Akino K, Mita H, Suzuki H, Sasaki Y, Kanaseki T, Takamura Y, Soejima H, Urano T, Yanagihara K, Endo T, Hinoda Y, Fujita M, Hosokawa M, Sato N, Tokino T, Imai K.
    Oncogene; 2004 Nov 25; 23(55):8876-86. PubMed ID: 15467734
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of HLA class I gene transcription in choriocarcinoma cells is controlled by the proximal promoter element and can be reversed by CIITA.
    Lefebvre S, Moreau P, Dausset J, Carosella ED, Paul P.
    Placenta; 1999 May 25; 20(4):293-301. PubMed ID: 10329350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.